The platform functions as a commercial operating layer, utilizing over 200 million industry-specific data points to synchronize strategy, systems, and execution. According to Chief Executive and Strategy Officer Hemal Somaiya, the goal is to shift from retrospective post-mortem reports to a real-time learning loop. This allows teams to move from identifying a performance trend to approving a specific next step without the traditional delays associated with manual dashboard reconciliation or vendor hand-offs.
Chief Operating Officer Stephen Onikoro noted that the rollout begins with existing clients, focusing on agentic, in-platform conversational insights. By unifying personal and non-personal channels, the software enables pharmaceutical teams to trace NPI-level evidence directly to governed execution. This approach eliminates the reliance on disconnected silos, ensuring that every identified driver of performance is immediately actionable within the CRM environment.

Comments (0)
No comments yet. Be the first!